<DOC>
	<DOCNO>NCT01999153</DOCNO>
	<brief_summary>The aim study Evaluate analgesic effect ropivacaine topical use thin skin graft donor site . For Patient need thin skin graft &lt; 320 cm2 , randomization do 2 group , one receive standard treatment ( 20 mL physiologic serum ) surgical intervention topical use recover alginate dressing ( Algosteril ) receive 20 mL Naropein surgical intervention alginate dressing . The hypothesis study administration ropivacaine decrease post-operative pain compare physiologic serum</brief_summary>
	<brief_title>Evaluation Analgesic Effect Ropivacaine Topical Use Thin Skin Graft Donor Site</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Alginic acid</mesh_term>
	<criteria>Patient old 18 year old Patient needing thin skin graft &lt; 320 cm2 possible thigh Patient read information letter sign informed consent Patient affiliate social security system Effective contraceptive method 3 month woman childbearing age Contraindication one medicine use ( allergy , intolerance , potential drug interaction ) Treatment classII III analgesic analgesic dose aspirin ( &gt; 500mg per day ) inclusion randomization time Preoperative EVA &gt; 0 skin graft donor site thigh Sensory disturbance low limb Cognitive disturbance allow investigation Pregnant lactate woman People deprived discernment People deprive liberty judicial administrative authority Protected adult ( guardianship trusteeship )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>skin graft</keyword>
	<keyword>donor site</keyword>
</DOC>